End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
83,500 KRW | +0.24% | +0.97% | -16.83% |
Jan. 30 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
2023 | SK Group Advances Net Zero Transition via Key Renewable Energy Deal | MT |
Sales 2024 * | 485B 353M | Sales 2025 * | 651B 473M | Capitalization | 6,539B 4.75B |
---|---|---|---|---|---|
Net income 2024 * | 31B 22.54M | Net income 2025 * | 118B 85.79M | EV / Sales 2024 * | 13.2 x |
Net cash position 2024 * | 145B 105M | Net cash position 2025 * | 261B 190M | EV / Sales 2025 * | 9.65 x |
P/E ratio 2024 * |
205
x | P/E ratio 2025 * |
50
x | Employees | 252 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35.75% |
1 day | +0.24% | ||
1 week | +0.97% | ||
Current month | -8.94% | ||
1 month | -11.83% | ||
3 months | -5.11% | ||
6 months | +11.63% | ||
Current year | -16.83% |
Managers | Title | Age | Since |
---|---|---|---|
Dong-Hoon Lee
CEO | Chief Executive Officer | 56 | 22-12-31 |
Choi Jonggil
PRN | Corporate Officer/Principal | - | 22-12-31 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 17-03-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Geun-Joo Hwang
BRD | Director/Board Member | 60 | 17-03-15 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 17-03-15 |
Young-Ju Bang
BRD | Director/Board Member | - | 19-08-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.83% | 2 M€ | -14.14% | ||
0.08% | 15 M€ | +11.24% | ||
0.03% | 2,808 M€ | +5.90% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 83,500 | +0.24% | 37,526 |
24-04-25 | 83,300 | -2.00% | 80,223 |
24-04-24 | 85,000 | +1.19% | 58,324 |
24-04-23 | 84,000 | -0.24% | 65,826 |
24-04-22 | 84,200 | +1.81% | 70,684 |
End-of-day quote Korea S.E., April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.83% | 4.75B | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B |
- Stock Market
- Equities
- A326030 Stock